A three month randomised, prospective , single-blind controlled study to determine the effect of two dairy lipid preparations on bone and calcium metabolism in normal post-menopausal women.
Not Applicable
Completed
- Conditions
- Bone MetabolismMetabolic and Endocrine - Normal metabolism and endocrine development and function
- Registration Number
- ACTRN12608000483358
- Lead Sponsor
- actopharma
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 75
Inclusion Criteria
Healthy women at least 5 years post -menopause
Exclusion Criteria
Osteoporosis (Bone Mineral Density(BMD) T score <2.5 at hip or spine)
concurrent major systemic illness
renal impairment
chronic liver disease
active major gastrointestinal disease
metabolic bone diease
use of glucocorticoids in preceding 12 mths
use of bisphosphonates or Hormone Replacement Therapy (HRT) or other medications known to cause osteoporosis or interfere with bone metabolism.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method